ATG-GCSF in New Onset Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael J Haller, M.D.
University of Florida
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California - San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- Barbara Davis Center
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami
Miami, Florida, United States
- University of South Florida Diabetes Center
Tampa, Florida, United States
- Indiana University-Riley Hospital for Children
Indianapolis, Indiana, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Columbia University-Naomi Berrie Diabetes Center
New York, New York, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Vanderbilt Eskind Diabetes Clinic
Nashville, Tennessee, United States
- Benaroya Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2014
- Primary completion
- 31 Aug 2017
- Completion
- 31 Aug 2018
- Last update posted
- 2 Mar 2020
- Registered enrollment
- 89
- Registry id
- NCT02215200
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.